FDA revokes emergency use of malaria drugs for COVID-19
  • 4 years ago
FDA revokes emergency use of malaria drugs for COVID-19
The U.S. Food and Drug Administration on Monday revoked its emergency use authorization for hydroxychloroquine to treat COVID-19, the drug championed by President Donald Trump to stave off the coronavirus.



Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Recommended